Evoke Pharma, Inc.
Evoke Pharma, Inc. (EVOK) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001403708 · EVOK · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001403708 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Evoke Pharma, Inc. (NASDAQ: EVOK) has submitted 665 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2013. As a Healthcare sector company with CIK 0001403708, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Evoke Pharma, Inc.'s most comprehensive regulatory disclosure. The most recent Evoke Pharma, Inc. 10-K was filed on 2025-03-13 for fiscal year ending 2025. Historical EVOK 10-K annual reports are available from 2007 through 2025.
Investors researching Evoke Pharma, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
EVOK SEC Filings · 8 questionsEvoke Pharma, Inc. (EVOK) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 665 filings and access original documents at no cost. Evoke Pharma, Inc.'s CIK is 0001403708.